The sight test fee Effectiveness for treatment for glaucoma remains unproved

BMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6965.1369b (Published 19 November 1994) Cite this as: BMJ 1994;309:1369
  1. L Clearkin
  1. Arrowe Park Hospital, Upton, Wirral, Merseyside L49 5PE

    EDITOR, - D A H Laidlaw and colleagues are concerned that the prevalence of blindness due to glaucoma may increase because of reduced uptake of screening since the introduction of the sight test fee.1 Their implication is that treatment …

    View Full Text

    Sign in

    Log in through your institution